These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29920340)

  • 1. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
    Bruzzì S; Sutti S; Giudici G; Burlone ME; Ramavath NN; Toscani A; Bozzola C; Schneider P; Morello E; Parola M; Pirisi M; Albano E
    Free Radic Biol Med; 2018 Aug; 124():249-259. PubMed ID: 29920340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive immunity: an emerging player in the progression of NAFLD.
    Sutti S; Albano E
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):81-92. PubMed ID: 31605031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.
    Sutti S; Bruzzì S; Albano E
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
    Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
    Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
    Barrow F; Khan S; Fredrickson G; Wang H; Dietsche K; Parthiban P; Robert S; Kaiser T; Winer S; Herman A; Adeyi O; Mouzaki M; Khoruts A; Hogquist KA; Staley C; Winer DA; Revelo XS
    Hepatology; 2021 Aug; 74(2):704-722. PubMed ID: 33609303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.
    Hendrikx T; Watzenböck ML; Walenbergh SM; Amir S; Gruber S; Kozma MO; Grabsch HI; Koek GH; Pierik MJ; Staufer K; Trauner M; Kalhan SC; Jonkers D; Hofker MH; Binder CJ; Shiri-Sverdlov R
    BMC Med; 2016 Jul; 14(1):107. PubMed ID: 27443391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.
    Hart KM; Fabre T; Sciurba JC; Gieseck RL; Borthwick LA; Vannella KM; Acciani TH; de Queiroz Prado R; Thompson RW; White S; Soucy G; Bilodeau M; Ramalingam TR; Arron JR; Shoukry NH; Wynn TA
    Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.
    Zhang F; Jiang WW; Li X; Qiu XY; Wu Z; Chi YJ; Cong X; Liu YL
    J Dig Dis; 2016 Jul; 17(7):464-74. PubMed ID: 27216040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.
    Li H; Xia N
    Front Immunol; 2024; 15():1447391. PubMed ID: 39372417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
    Hu Y; Zhang H; Li J; Cong X; Chen Y; He G; Chi Y; Liu Y
    J Gastroenterol Hepatol; 2016 Mar; 31(3):676-84. PubMed ID: 26430807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression.
    Dallio M; Sangineto M; Romeo M; Villani R; Romano AD; Loguercio C; Serviddio G; Federico A
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
    Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
    Front Immunol; 2018; 9():1994. PubMed ID: 30233587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.
    Sun G; Jin H; Zhang C; Meng H; Zhao X; Wei D; Ou X; Wang Q; Li S; Wang T; Sun X; Shi W; Tian D; Liu K; Xu H; Tian Y; Li X; Guo W; Jia J; Zhang Z; Zhang D
    Cell Rep; 2018 Dec; 25(13):3786-3799.e4. PubMed ID: 30590049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Her Z; Tan JHL; Lim YS; Tan SY; Chan XY; Tan WWS; Liu M; Yong KSM; Lai F; Ceccarello E; Zheng Z; Fan Y; Chang KTE; Sun L; Chang SC; Chin CL; Lee GH; Dan YY; Chan YS; Lim SG; Chan JKY; Chandy KG; Chen Q
    Front Immunol; 2020; 11():580968. PubMed ID: 33013934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
    Ma C; Kesarwala AH; Eggert T; Medina-Echeverz J; Kleiner DE; Jin P; Stroncek DF; Terabe M; Kapoor V; ElGindi M; Han M; Thornton AM; Zhang H; Egger M; Luo J; Felsher DW; McVicar DW; Weber A; Heikenwalder M; Greten TF
    Nature; 2016 Mar; 531(7593):253-7. PubMed ID: 26934227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model.
    Lu Y; Lin Y; Huang X; Wu S; Wei J; Yang C
    Int J Mol Med; 2019 Jun; 43(6):2398-2408. PubMed ID: 30942432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
    Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.